Greenberg Traurig’s Life Sciences & Medical Technology Group Hosts 6th Annual Deal-Making Workshop and Reception in San Francisco

Share Article

For the sixth consecutive year, Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group hosted two events coinciding with the JP Morgan Healthcare Conference in San Francisco.

For the sixth consecutive year, Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group hosted two events coinciding with the JP Morgan Healthcare Conference in San Francisco.

On Jan. 14 the group presented the lunchtime panel discussion, “Insiders’ Views of Deal Makings,” where seasoned executives from leading life sciences companies shared current trends, best practices, and pitfalls of deals including M&A, licensing, joint ventures, and strategic collaborations. They also shared predictions on what 2020 will hold for deal making. Panelists included:

  • Debbie Alexander, Director, Business Development, 23andMe
  • Shaun Grady, Senior VP, Business Development Operations, AstraZeneca
  • Dr. Robert Mittendorff, Partner, Norwest Venture Partners
  • Jeremy Sohn, Vice President, Global Head of Digital Business Development & Licensing, Novartis

The panel was moderated by Fiona Adams, co-chair of Greenberg Traurig’s Global Corporate Practice and managing shareholder of the London office, and Wayne H. Elowe, co-chair of the firm’s global Life Sciences & Medical Technology Group and the Atlanta office Corporate Practice. David J. Dykeman, patent attorney and co-chair of the global Life Sciences & Medical Technology Group and Boston officeIntellectual Property & Technology Group, gave opening remarks.

The program was preceded by a private wine tasting and networking reception on Jan. 13, attended by more than 300 health care industry executives and investors.

In addition, Kate Black, a shareholder in the firm’s Data, Privacy & Cybersecurity Practice in the Miami office, introduced companies at the Biotech Showcase on Jan. 14.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo Martinez
@GT_Law
Follow >
Visit website